AMRX — AMNEAL PHARMACEUTICALS INC

Ownership history in CAXTON ASSOCIATES LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which CAXTON ASSOCIATES LP reported a position in AMNEAL PHARMACEUTICALS INC (AMRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.07% (2023 Q3)
Avg. % of fund
0.03%
First filed
2023 Q3
Last filed
2024 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q3 REDUCED 29,150 -62,331 -68.1% 0.01% $243K $8.32
2024 Q1 ADDED 91,481 +8,088 +9.7% 0.03% $554K $6.06
2023 Q4 REDUCED 83,393 -36,887 -30.7% 0.03% $506K $6.07
2023 Q3 INITIATED 120,280 — — 0.07% $508K —
% of Fund (quarterly)    AMRX price (monthly, adj. close)

Other funds also holding AMRX

As of 2025 Q4 — sorted by position size

TPG GP A, LLC 3Y 5.78% Westshore Wealth, LLC 3Y 5.76% Phocas Financial Corp. 3Y 7Y 2.15% Rubric Capital Management LP 3Y 7Y 1.86% PFM Health Sciences, LP 3Y 7Y 1.84% BlackBarn Capital Partners LP 1.3% Nantahala Capital Management, LLC 3Y 7Y 1.02% Penn Capital Management Company, LLC 3Y 7Y 1.01% Jackson Creek Investment Advisors LLC 3Y 0.83% Informed Momentum Co LLC 3Y 7Y 0.6%
← Back to CAXTON ASSOCIATES LP Holdings